Genmab A-S
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $6,441,000 | $5,540,000 | $5,402,000 | $4,143,000 |
Gross Profit | 6,104,000 | 5,267,000 | 5,212,000 | 3,958,000 |
EBITDA | 2,355,000 | 1,849,000 | 2,146,000 | 861,000 |
EBIT | 2,240,000 | 1,737,000 | 2,077,000 | 801,000 |
Net Income | 3,845,000 | 1,266,000 | 1,408,000 | 1,325,000 |
Net Change In Cash | 6,441,000 | 5,540,000 | 5,402,000 | 4,143,000 |
Free Cash Flow | 2,618,000 | 1,985,000 | 1,486,000 | 1,485,000 |
Cash | 9,858,000 | 6,342,000 | 4,331,000 | 14,670,000 |
Basic Shares | 64,153 | 64,884 | 64,884 | 65,659 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $21,526,000 | $16,474,000 | $14,595,000 | $8,482,000 |
Gross Profit | 20,541,000 | 16,248,000 | 14,595,000 | 8,482,000 |
EBITDA | 7,390,000 | 5,561,000 | 7,043,000 | 3,147,000 |
EBIT | 6,977,000 | 5,321,000 | 6,753,000 | 2,897,000 |
Net Income | 7,844,000 | 4,352,000 | 5,452,000 | 2,957,000 |
Net Change In Cash | 21,526,000 | 16,474,000 | 14,595,000 | 8,482,000 |
Free Cash Flow | 7,584,000 | 7,004,000 | 3,595,000 | 1,976,000 |
Cash | 9,858,000 | 14,867,000 | 9,893,000 | 8,957,000 |
Basic Shares | 64,632 | 65,914 | 66,009 | 66,045 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | $0.83 |
2024-09-30 | $0.29 |
2024-06-30 | $0.31 |
2024-03-31 | $0.29 |
